Cloning and expression of synthetic genes encoding the broad antimicrobial spectrum bacteriocins SRCAM 602, OR-7, E-760, and L-1077, by recombinant pichia pastoris

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Arbulu, Sara ^a   Jiménez, Juan J ^a   Gútiez, Loreto ^a   Cintas, Luis M ^a   Herranz, Carmen ^a   Hernández, Pablo E ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM SULFATE; ANTIINFECTIVE AGENT; BACTERIOCIN; L 1077; OR 7; PEPTIDE FRAGMENT; SRCAM 602; SYNTHETIC DNA; UNCLASSIFIED DRUG; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CATION EXCHANGE; CODON USAGE; CONTROLLED STUDY; GEL FILTRATION; GENE EXPRESSION; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; KOMAGATAELLA PASTORIS; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROTITER PLATE ASSAY; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; PEDIOCOCCUS; PEDIOCOCCUS DAMNOSUS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RECOMBINANT PLASMID; REVERSED PHASE LIQUID CHROMATOGRAPHY; TRANSFORMED CELL; BIOSYNTHESIS; GENETICS; METABOLISM; PICHIA; PROCEDURES;

PICHIA PASTORIS;

BACTERIOCINS; CLONING, MOLECULAR; GENES, SYNTHETIC; PICHIA; RECOMBINANT PROTEINS;

EID: 84925337184     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/767183     Document Type: Article

References (44)

1. C. T. Lohans and J. C. Vederas, "Development of class IIa bacteriocins as therapeutic agents, " International Journal of Microbiology, vol. 2012, Article ID 386410, 13 pages, 2012.
2. P. D. Cotter, R. P. Ross, and C. Hill, "Bacteriocins-a viable alternative to antibiotics" Nature Reviews Microbiology, vol. 11, no. 2, pp. 95-105, 2013.
3. S. Yang, Y. Kuang, H. Li et al., "Enhanced production of recombinant secretory proteins in Pichia pastoris by optimizing Kex2 P1' site, " PLoS ONE, vol. 8, no. 9, Article ID e75347, 2013.
4. P. D. Cotter, C. Hill, and R. P. Ross, "Food microbiology: bacteriocins: developing innate immunity for food, " Nature Reviews Microbiology, vol. 3, no. 10, pp. 777-788, 2005.
5. D. Drider, G. Fimland, Y. Héchard, L. M. McMullen, and H. Prévost, "The continuing story of class IIa bacteriocins, " Microbiology and Molecular Biology Reviews, vol. 70, no. 2, pp. 564-582, 2006.
6. J. Borrero, J. J. Jiménez, L. Gútiez, C. Herranz, L. M. Cintas, and P. E. Hernández, "Protein expression vector and secretion signal peptide optimization to drive the production, secretion, and functional expression of the bacteriocin enterocin A in lactic acid bacteria, " Journal of Biotechnology, vol. 156, no. 1, pp. 76-86, 2011.
7. N. S. Parachin, K. C. Mulder, A. A. B. Viana, S. C. Dias, and O. L. Franco, "Expression systems for heterologous production of antimicrobial peptides, " Peptides, vol. 38, no. 2, pp. 446-456, 2012.
8. J. J. Jiménez, J. Borrero, D. B. Diep et al., "Cloning, production, and functional expression of the bacteriocin sakacin A (SakA) and two SakA-derived chimeras in lactic acid bacteria (LAB) and the yeasts Pichia pastoris and Kluyveromyces lactis, " Journal of Industrial Microbiology and Biotechnology, vol. 40, no. 9, pp. 977-993, 2013.
9. M. Gao and Z. Shi, "Process control and optimization for heterologous protein production by methylotrophic pichia pastoris, " Chinese Journal of Chemical Engineering, vol. 21, no. 2, pp. 216-226, 2013.
10. M. Ahmad, M. Hirz, H. Pichler, and H. Schwab, "Proteinexpression in Pichia pastoris: recent achievements and perspectives for heterologous protein production, " AppliedMicrobiology and Biotechnology, vol. 98, pp. 5301-5317, 2014.
11. J. Borrero, G. Kunze, J. Jiménez et al., "Cloning, production, and functional expression of the bacteriocin enterocin A, produced by Enterococcus faecium T136, by the Yeasts Pichia pastoris, Kluyveromyces lactis, Hansenula polymorpha, and Arxula adeninivorans, " Applied and Environmental Microbiology, vol. 78, no. 16, pp. 5956-5961, 2012.
12. J. J. Jiménez, J. Borrero, L. Gútiez et al., "Use of synthetic genes for cloning, production and functional expression of the bacteriocins enterocin A and bacteriocin E 50-52 by Pichia pastoris and Kluyveromyces lactis, "Molecular Biotechnology, vol. 56, no. 6, pp. 571-583, 2014.
13. R. A. J. Darby, S. P. Cartwright, M. V. Dilworth, and R. M. Bill, "Which yeast species shall i choose Saccharomyces cerevisiae versus Pichia pastoris, " Methods in Molecular Biology, vol. 866, pp. 11-23, 2012.
14. F. Oberg, J. Sjöhamn, M. T. Conner, R. M. Bill, and K. Hedfalk, "Improving recombinant eukaryotic membrane protein yields in Pichia pastoris: the importance of codon optimization and clone selection, "MolecularMembrane Biology, vol. 28, no. 6, pp. 398-411, 2011.
15. N. J. Stern, E. A. Svetoch, B. V. Eruslanov et al., "Paenibacillus polymyxa purified bacteriocin to control Campylobacter jejuni in chickens, " Journal of Food Protection, vol. 68, no. 7, pp. 1450-1453, 2005.
16. E. A. Svetoch, N. J. Stern, B. V. Eruslanov et al., "Isolation of Bacillus circulans and Paenibacillus polymyxa strains inhibitory to Campylobacter jejuni and characterization of associated bacteriocins, " Journal of Food Protection, vol. 68, no. 1, pp. 11-17, 2005.
17. N. J. Stern, E. A. Svetoch, B. V. Eruslanov et al., "Isolation of a Lactobacillus salivarius strain and purification of its bacteriocin, which is inhibitory to Campylobacter jejuni in the chicken gastrointestinal system, " Antimicrobial Agents and Chemotherapy, vol. 50, no. 9, pp. 3111-3116, 2006.
18. E. A. Svetoch, B. V. Eruslanov, V. P. Levchuk et al., "Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin, including the antimicrobial activity spectrum, " Applied and EnvironmentalMicrobiology, vol. 77, no. 8, pp. 2749-2754, 2011.
19. J. E. Line, E. A. Svetoch, B. V. Eruslanov et al., "Isolation and purification of enterocin E-760 with broad antimicrobial activity against Gram-positive and Gram-negative bacteria, " AntimicrobialAgents and Chemotherapy, vol. 52, no. 3, pp. 1094-1100, 2008.
20. E. A. Svetoch, B. V. Eruslanov, V. V. Perelygin et al., "Diverse antimicrobial killing by Enterococcus faecium E 50-52 bacteriocin, " Journal of Agricultural and Food Chemistry, vol. 56, no. 6, pp. 1942-1948, 2008.
21. E. A. Svetoch and N. J. Stern, "Bacteriocins to control Campylobacter spp. in poultry-a review, " Poultry Science, vol. 89, no. 8, pp. 1763-1768, 2010.
22. J. Gutiérrez, R. Criado, M. Martín, C. Herranz, L. M. Cintas, and P. E. Hernández, "Production of enterocin P, an antilisterial pediocin-like bacteriocin from Enterococcus faecium P13, in Pichia pastons, "AntimicrobialAgents and Chemotherapy, vol. 49, no. 7, pp. 3004-3008, 2005.
23. A. Shevchenko, A. Loboda, W. Ens, and K. G. Standing, "MALDI quadrupole time-of-flight mass spectrometry: a powerful tool for proteomic research, " Analytical Chemistry, vol. 72, no. 9, pp. 2132-2141, 2000.
24. World Health Organization (WHO), "Antimicrobial resistance: global report on surveillance 2014, " http://www.searo.who.int/thailand/publications/2013/9789241564748/en/.
25. E. Böer, G. Steinborn, G. Kunze, and G. Gellissen, "Yeast expression platforms, " Applied Microbiology and Biotechnology, vol. 77, no. 3, pp. 513-523, 2007.
26. J. M. Cregg, J. L. Cereghino, J. Shi, and D. R. Higgins, "Recombinantprotein expression inPichia pastoris, " Applied Biochemistry and Biotechnology-Part B Molecular Biotechnology, vol. 16, no. 1, pp. 23-52, 2000.
27. O. J. Burrowes, G. Diamond, and T. C. Lee, "Recombinant expression of pleurocidin cDNA using the Pichia pastoris expression system, " Journal of Biomedicine and Biotechnology, vol. 2005, no. 4, pp. 374-384, 2005.
28. K. R. Love, T. J. Politano, V. Panagiotou, B. Jiang, T. A. Stadheim, and J. C. Love, "Systematic single-cell analysis of pichia pastoris reveals secretory capacity limits productivity, " PLoS ONE, vol. 7, no. 6, Article ID e37915, 2012.
29. H. A. Kang, E.-S. Choi, W.-K. Hong et al., "Proteolytic stability of recombinant human serumalbumin secreted in the yeast Saccharomyces cerevisiae, " AppliedMicrobiology and Biotechnology, vol. 53, no. 5, pp. 575-582, 2000.
30. M. W. T. Werten and F. A. De Wolf, "Reduced proteolysis of secreted gelatin and Yps1-mediated-factor leader processing in a Pichia pastoris kex2 disruptant, " Applied and Environmental Microbiology, vol. 71, no. 5, pp. 2310-2317, 2005.
31. Z. Ni, X. Zhou, X. Sun, Y. Wang, and Y. Zhang, "Decrease of hirudin degradation by deleting the KEX1 gene in recombinant Pichia pastoris, " Yeast, vol. 25, no. 1, pp. 1-8, 2008.
32. J. Borrero, D. A. Brede, M. Skaugen et al., "Characterization of garvicin ML, a novel circular bacteriocin produced by Lactococcus garvieae DCC43, isolated from mallard ducks (Anas platyrhynchos), " Applied and Environmental Microbiology, vol. 77, no. 1, pp. 369-373, 2011.
33. Y. Zhao and O. N. Jensen, "Modification-specific proteomics: strategies for characterization of post-translational modifications using enrichment techniques, " Proteomics, vol. 9, no. 20, pp. 4632-4641, 2009.
34. B. Gasser, M. Saloheimo, U. Rinas et al., "Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview, " Microbial Cell Factories, vol. 7, article 11, 2008.
35. A. Stolz and D. H. Wolf, "Endoplasmic reticulum associated protein degradation: a chaperone assisted journey to hell, " Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1803, no. 6, pp. 694-705, 2010.
36. E. Breukink, I. Wiedemann, C. van Kraaij, O. P. Kuipers, H.-G. Sahl, and B. de Kruijff, "Use of the cell wail precursor lipid II by a pore-forming peptide antibiotic, " Science, vol. 286, no. 5448, pp. 2361-2364, 1999.
37. D. B. Diep, M. Skaugen, Z. Salehian, H. Holo, and I. F. Nes, "Commonmechanisms of target cell recognition and immunity for class II bacteriocins, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 7, pp. 2384-2389, 2007.
38. M. Kjos, J. Borrero, M. Opsata et al., "Target recognition, resistance, immunity and genome mining of class II bacteriocins from Gram-positive bacteria, " Microbiology, vol. 157, no. 12, pp. 3256-3267, 2011.
39. M. Phelan, A. Aherne, R. J. FitzGerald, and N. M. O'Brien, "Casein-derived bioactive peptides: biological effects, industrial uses, safety aspects and regulatory status, " International Dairy Journal, vol. 19, no. 11, pp. 643-654, 2009.
40. G. D. Brand, M. T. Q. Magalhães, M. L. P. Tinoco et al., "Probing protein sequences as sources for encrypted antimicrobial peptides, " PLoS ONE, vol. 7, no. 9, Article ID e45848, 2012.
41. E. A. Svetoch, V. P. Levchuk, V. D. Pokhilenko et al., "Inactivating methicillin-resistant Staphylococcus aureus and other pathogens by use of bacteriocins OR-7 and E 50-52, " Journal of Clinical Microbiology, vol. 46, no. 11, pp. 3863-3865, 2008.
42. J. Sánchez, J. Borrero, B. Gómez-Sala et al., "Cloning and heterologous production of hiracin JM79, a Sec-dependent bacteriocin produced by Enterococcus hirae DCH5, in lactic acid bacteria and Pichia pastoris, " Applied and Environmental Microbiology, vol. 74, no. 8, pp. 2471-2479, 2008.
43. C. T. Lohans, Z. Huang, M. J. Van Belkum et al., "Structural characterization of the highly cyclized lantibiotic paenicidin A via a partial desulfurization/reduction strategy, " Journal of the American Chemical Society, vol. 134, no. 48, pp. 19540-19543, 2012.
44. C. T. Lohans, M. J. VanBelkum, S. A. Cochrane et al., "Biochemical, structural, and genetic characterization of tridecaptin A1, an antagonist of Campylobacter jejuni, " ChemBioChem, vol. 15, no. 2, pp. 243-249, 2014.